Compugen Ltd (CGEN)

6.55
0.05 0.76
NASDAQ : Health Care
Prev Close 6.60
Open 6.61
Day Low/High 6.52 / 6.67
52 Wk Low/High 4.32 / 7.79
Volume 25.84K
Avg Volume 117.00K
Exchange NASDAQ
Shares Outstanding 50.91M
Market Cap 346.69M
EPS -0.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Compugen Discloses Lead Therapeutic Candidate For CGEN-15029 Immuno-Oncology Program

Compugen Discloses Lead Therapeutic Candidate For CGEN-15029 Immuno-Oncology Program

IND filing for COM701 anticipated next year

Compugen Enters Oversold Territory (CGEN)

Compugen Enters Oversold Territory (CGEN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

'Mad Money' Lightning Round: I'm Buying Buffett's Berkshire Hathaway

'Mad Money' Lightning Round: I'm Buying Buffett's Berkshire Hathaway

Cramer says he's no longer negative on Advanced Micro Devices and thinks Micron Technology is OK.

Jim Cramer's 'Mad Money' Recap: Own This Rally and Buy These Stocks

Jim Cramer's 'Mad Money' Recap: Own This Rally and Buy These Stocks

When you get an unexpected rally, just go with it, Cramer says.

Compugen Presents Results For CGEN-15029 Immuno-Oncology Therapeutic Program

Compugen Presents Results For CGEN-15029 Immuno-Oncology Therapeutic Program

Multiple blocking antibodies discovered for Compugen novel immune checkpoint target candidate for treatment of cancer

Compugen Becomes Oversold (CGEN)

Compugen Becomes Oversold (CGEN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Relative Strength Alert For Compugen

Relative Strength Alert For Compugen

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Compugen Achieves Third Preclinical Milestone In Cancer Immunotherapy Collaboration With Bayer

Compugen Achieves Third Preclinical Milestone In Cancer Immunotherapy Collaboration With Bayer

Compugen Ltd. ( NASDAQ: CGEN), a leading predictive drug discovery company, announced today that it has achieved the third preclinical milestone pursuant to its cancer immunotherapy collaboration with Bayer HealthCare...

Compugen To Present At The Oppenheimer Healthcare Conference In New York

Compugen To Present At The Oppenheimer Healthcare Conference In New York

Compugen Ltd. ( NASDAQ: CGEN), a leading predictive drug discovery company, today announced that Ari Krashin, Chief Financial Officer of Compugen, will present a corporate overview and update at the Oppenheimer 26th Annual...

Compugen To Present At Jefferies 2015 Global Healthcare Conference In London

Compugen To Present At Jefferies 2015 Global Healthcare Conference In London

Compugen Ltd. ( NASDAQ: CGEN), a leading predictive drug discovery company, today announced that Dr.

Compugen Ltd. Reports 3rd Quarter 2015 Financial Results

Compugen Ltd. Reports 3rd Quarter 2015 Financial Results

Compugen Ltd. ( NASDAQ: CGEN), a leading predictive drug discovery company, today reported financial results for the third quarter ending September 30, 2015.

Compugen Third Quarter 2015 Conference Call Scheduled For Tuesday, November 3, 2015 At 10:00 AM ET

Compugen Third Quarter 2015 Conference Call Scheduled For Tuesday, November 3, 2015 At 10:00 AM ET

Compugen Ltd. (NASDAQ: CGEN) today announced that the Company will host a conference call at 10:00 AM ET on Tuesday, November 3, 2015 to review third quarter 2015 results.

Compugen Discloses Antibody Drug Conjugate Program Results At The World ADC Summit In San Diego

Compugen Discloses Antibody Drug Conjugate Program Results At The World ADC Summit In San Diego

Compugen Ltd. ( NASDAQ: CGEN), a leading predictive drug discovery company, today announced that the Company will present the status of its predictive target discovery pipeline for novel antibody drug conjugates (ADC's),...

Compugen Discloses New Results Supporting CGEN-15052 As Novel Immune Checkpoint Target Candidate For Treatment Of Cancer

Compugen Discloses New Results Supporting CGEN-15052 As Novel Immune Checkpoint Target Candidate For Treatment Of Cancer

In a poster presentation today at The Inaugural International Cancer Immunotherapy Conference: Translating Science into Survival, being held in New York City, Arthur Machlenkin, Ph.

Compugen To Present At Upcoming Immuno-Oncology And Rheumatology Conferences

Compugen To Present At Upcoming Immuno-Oncology And Rheumatology Conferences

Compugen Ltd. ( NASDAQ: CGEN), a leading predictive drug discovery company, today announced that aspects of its immuno-oncology programs and its lead autoimmune program will be presented at four upcoming scientific...

Compugen Becomes Oversold (CGEN)

Compugen Becomes Oversold (CGEN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Compugen Ltd. Reports 2nd Quarter 2015 Financial Results

Compugen Ltd. Reports 2nd Quarter 2015 Financial Results

Compugen Ltd. ( NASDAQ: CGEN), a leading predictive drug discovery company, today reported financial results for the second quarter ending June 30, 2015.

Compugen Becomes Oversold (CGEN)

Compugen Becomes Oversold (CGEN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Compugen Second Quarter 2015 Conference Call Scheduled For Tuesday, August 4, 2015 At 10:00 AM ET

Compugen Second Quarter 2015 Conference Call Scheduled For Tuesday, August 4, 2015 At 10:00 AM ET

Compugen Ltd. ( NASDAQ: CGEN), a leading predictive drug discovery company, today announced that the Company will host a conference call at 10:00 AM ET on Tuesday, August 4, 2015 to review the second quarter 2015 results.